Penicillin resistance in pneumococcal pneumonia

被引：5

作者：

Cunha, BA

机构：

[1] Winthrop Univ Hosp, Div Infect Dis, Mineola, NY 11501 USA

[2] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA

来源：

POSTGRADUATE MEDICINE | 2003年 / 113卷 / 01期

关键词：

D O I：

10.3810/pgm.2003.01.1349

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antibiotic resistance is a potential problem around the world. Among the bacteria that cause community-acquired pneumonia (CAP), resistance in Streptococcus pneumoniae is a primary concern. Resistance can occur through genetic mutations in the bacterial strain itself or can be acquired through use of some antibiotics that have a high resistance potential. In this article, Dr Cunha explores the misperceptions about antibiotic resistance and its occurrence, as well as the most appropriate therapy for CAP in the clinical setting.

引用

收藏

页码：42 / +

页数：8

相关论文

共 11 条

[1] Use of penicillin MICs to predict in vitro activity of other β-lactam antimicrobial agents against Streptococcus pneumoniae [J].

Brueggemann, AB ;

Pfaller, MA ;

Doern, GV .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :367-369

[2] Effective antibiotic-resistance control strategies [J].

Cunha, BA .

LANCET, 2001, 357 (9265) :1307-1308

[3] Community-acquired pneumonia - Diagnostic and therapeutic approach [J].

Cunha, BA .

MEDICAL CLINICS OF NORTH AMERICA, 2001, 85 (01) :43-+

[4]

CUNHA BA, 2000, INFECT DIS PRACT, V24, P30

[5]

Cunha Burke A, 2002, Semin Respir Infect, V17, P204, DOI 10.1053/srin.2002.34686

[6] Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in spain [J].

García-Rey, C ;

Aguilar, L ;

Baquero, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3481-3482

[7] The drug-resistant pneumococcus - Clinical relevance, therapy, and prevention [J].

Harwell, JI ;

Brown, RB .

CHEST, 2000, 117 (02) :530-541

[8] A fresh look at the definition of susceptibility of Streptococcus pneumoniae to β-lactam antibiotics [J].

Musher, DM ;

Bartlett, JG ;

Doern, GV .

ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (21) :2538-2544

[9] Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents [J].

Pihlajamäki, M ;

Kotilainen, P ;

Kaurila, T ;

Klaukka, T ;

Palva, E ;

Huovinen, P ;

Kostiala-Thompson, A ;

Renkonen, R ;

Muotiala, A ;

Vaara, M ;

Sivonen, A ;

Jousimies-Somer, H ;

Laitinen, K ;

Korpela, J ;

Kaukoranta-Tolvanen, SS ;

Hiekkaniemi, H ;

Hirvonen, P ;

Nissinen, A ;

Ruuska, P ;

Ahonen, E ;

Jägerroos, H ;

Räisänen, S ;

Larinkari, U ;

Forsblom, B ;

Katila, ML ;

Färkkäinen, U ;

Sarkkinen, H ;

Kärpänoja, P ;

Kauppinen, M ;

Paltemaa, S ;

Kärkkäinen, P ;

Silvennoinen-Kassinen, S ;

Lantto, K ;

Koskela, M ;

Pietarinen, I ;

Klossner, ML ;

Pajarre, S ;

Oinonen, S ;

Ratia, V ;

Grönroos, P ;

Vuento, R ;

Liimatainen, O ;

Siro, MR ;

Eerola, E ;

Maninen, R ;

Meurman, O ;

Luukkonen, S ;

Strandén, P ;

Lager, K .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :483-488

[10]

Quintiliani R, 1996, INFECT DIS CLIN PRAC, V5, pS37